Safetac® is a proprietary, patented soft silicone adhesive technology developed and owned by Mölnlycke Health Care, a world-leading Swedish medical solutions company. Unlike traditional adhesives that can cause pain and skin stripping, Safetac is designed to adhere gently to dry skin while avoiding the moist wound bed, significantly reducing pain and trauma during dressing changes. Core Technology and Benefits Safetac serves as the original "less-pain" wound contact layer, revolutionizing advanced wound care since its introduction. Minimal Trauma: It does not stick to the moist wound, allowing for easy removal without damaging new tissue or intact skin. Leak Protection: The technology seals wound margins to prevent exudate (fluid) from leaking onto surrounding skin, which minimizes the risk of maceration (skin breakdown). Evidence-Based: Performance is backed by more than 450 peer-reviewed findings, including over 30 randomized controlled studies. Economic Impact: By supporting faster natural healing and reducing skin damage, Safetac can help lower overall wound treatment costs. History and Development Safetac was invented in 1989 by Tomas Fabo, a young product designer at Mölnlycke. Origin: Fabo was driven by the pain he saw patients endure during dressing removals. He experimented in his own kitchen to develop the silicone adhesive. Launch: The technology first debuted in the Mepitel® range in 1989. Legacy: Over 30 years since its launch, Safetac remains a core component of Mölnlycke’s advanced dressing ranges, used by hundreds of millions of patients worldwide. Parent Company: Mölnlycke Health Care While Safetac is a brand of technology, it is exclusively managed by Mölnlycke Health Care. Founded: 1849 as a textile manufacturer in Gothenburg, Sweden. Global Reach: Operations and distribution span approximately 100 countries, with about 7,500 employees. Ownership: The company is wholly owned by Investor AB, an investment arm of the Wallenberg family. Financials: In 2024, Mölnlycke achieved annual sales of approximately €2.064 billion. Key Products Featuring Safetac Safetac technology is integrated into several major product lines for acute and chronic wound management: Mepilex®: A range of soft, conformable foam dressings for chronic wounds like leg and foot ulcers. Mepilex® Border Flex: Next-generation bordered foam dressings designed to stay in place and conform to body contours. Mepitel®: The original one-sided or two-sided wound contact layer that allows exudate to pass through to a secondary dressing. Mepiform®: A self-adherent dressing used specifically for the management of hypertrophic and keloid scars. Mepilex® Ag: Silver-impregnated dressings that provide antimicrobial protection for burns and infected wounds.